Such researchcan not only identify risk factors associated with readmission and systematicallyevaluate the effects of medication changes on immune markers, but also offer anin-depth analysis of the potential roles that immune-related indicators, such asIL-5, EOS, and IgA, play in the pathogenesis and progression of schizophrenia. Here, CD79A is linked to schizophrenia.